Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone (Q28201146)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2001)

edit

Language	Label	Description	Also known as
English	Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone	scientific article (publication date: 2001)

Statements

instance of

scholarly article

0 references

title

Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone (English)

0 references

main subject

patient

0 references

fluoxetine

1 reference

based on heuristic

inferred from title

author name string

M Ferreri

series ordinal

1

0 references

F Lavergne

series ordinal

2

0 references

I Berlin

series ordinal

3

0 references

C Payan

series ordinal

4

0 references

A J Puech

series ordinal

5

0 references

language of work or name

English

0 references

publication date

January 2001

0 references

published in

Acta Psychiatrica Scandinavica

0 references

volume

103

0 references

issue

1

0 references

page(s)

66-72

0 references

cites work

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2001.00148.X

retrieved

21 January 2018

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00148.X

retrieved

21 January 2018

A rating scale for depression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00148.X

retrieved

21 January 2018

Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00148.X

retrieved

21 January 2018

Serotonin reuptake inhibitor withdrawal

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2001.00148.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1600-0447.2001.00148.X

0 references

10.1034/J.1600-0447.2001.00148.X

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3036812

OpenCitations bibliographic resource ID

3036812

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3036812

PubMed publication ID

11202131

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3036812

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28201146&oldid=1513557294"